{"id":"b2ed43bc-7a8f-52c9-8485-9be557b385c9","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-ileal-glp1","predicate":"increases","statement":"Fasting and postprandial GLP-1 rose with all metformin treatments, with day-5 to baseline AUC ratios of 1.6-1.9.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"55dc289e-1779-5b5c-8771-4937cfd15b65","mechanism_event_label":"Gut hormones rose alongside the glucose effect.","subject":{"id":"519971b1-5aef-5ad7-8022-840144855cd0","slug":"metformin","display_name":"Metformin","entity_type_key":"drug"},"object":{"id":"4853afc6-9eaa-547f-91d7-c4dd90082351","slug":"glp-1","display_name":"Glucagon-like peptide 1 / GLP-1","entity_type_key":"peptide"},"evidence_count":1,"mechanism_event":{"id":"55dc289e-1779-5b5c-8771-4937cfd15b65","stable_key":"8b3cf083-ea9c-54f5-b42b-bf1fef5b2978:metformin-ileal-glp1-event","event_type":"observed_intervention","label":"Gut hormones rose alongside the glucose effect.","description":"Fasting and postprandial GLP-1 rose with all metformin treatments, with day-5 to baseline AUC ratios of 1.6-1.9.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"9086d887-f5ea-5dfb-a68f-adb2c2bda3c7","slug":"plasma-glp1-response","display_name":"Plasma GLP-1 response in the specified meal or glucose challenge","entity_type_key":"cellular_process"},"role":"measured_response","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"519971b1-5aef-5ad7-8022-840144855cd0","slug":"metformin","display_name":"Metformin","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"4853afc6-9eaa-547f-91d7-c4dd90082351","slug":"glp-1","display_name":"Glucagon-like peptide 1 / GLP-1","entity_type_key":"peptide"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/metformin-research/27216492.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"c874a5c13e2e709b4b36040f281e2b187e7956b4610decddc35403170c0ed45d\", \"start_char\": 0, \"end_char\": 3863, \"text_sha256\": \"c874a5c13e2e709b4b36040f281e2b187e7956b4610decddc35403170c0ed45d\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Two randomised crossover trials of delayed-release metformin targeted to the ileum","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Delayed-release versus immediate-release metformin over 5 to 7 day periods","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The dissociation of effect from plasma exposure is the key observation. Funded by the manufacturer of the delayed-release formulation, which the record retains.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"metformin","display_name":"Metformin","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Gut hormones rose alongside the glucose effect.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[metformin-p27216492] Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. (2016). https://pubmed.ncbi.nlm.nih.gov/27216492/ DOI: 10.1007/s00125-016-3992-6","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Distal small intestine","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"bce4cdb6-d260-5262-979c-81bac0c4de8b","evidence_kind":"source_excerpt","locator":"Lines 840-851","start_line":840,"end_line":851,"excerpt":"### metformin-ileal-glp1\nFasting and postprandial GLP-1 rose with all metformin treatments, with day-5 to baseline AUC ratios of 1.6-1.9.\nCondition category: normal\nnutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake.\nplain_language: Gut hormones rose alongside the glucose effect.\norganism: Human\ntissue_or_cell_type: Distal small intestine\nexperimental_model: Two randomised crossover trials of delayed-release metformin targeted to the ileum\nlimitations: The dissociation of effect from plasma exposure is the key observation. Funded by the manufacturer of the delayed-release formulation, which the record retains.\nexposure: Delayed-release versus immediate-release metformin over 5 to 7 day periods\nevidence_span: {\"source_cache\": \"artifacts/metformin-research/27216492.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"c874a5c13e2e709b4b36040f281e2b187e7956b4610decddc35403170c0ed45d\", \"start_char\": 0, \"end_char\": 3863, \"text_sha256\": \"c874a5c13e2e709b4b36040f281e2b187e7956b4610decddc35403170c0ed45d\"}\n[metformin-p27216492] Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. (2016). https://pubmed.ncbi.nlm.nih.gov/27216492/ DOI: 10.1007/s00125-016-3992-6","model_system":"Two randomised crossover trials of delayed-release metformin targeted to the ileum","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [metformin-p27216492] Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. (2016). https://pubmed.ncbi.nlm.nih.gov/27216492/ DOI: 10.1007/s00125-016-3992-6","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d0474bd9-7cfd-5695-a152-12f3633a6813","stable_key":"import-8b3cf083-ea9c-54f5-b42b-bf1fef5b2978","title":"Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"0b51d0759aeeb88ac5b3a6277245a196b2bb024d7c32ec89379ed428fb06bfb5","revision_id":"0405c75e-f06e-5af7-a642-1777802f6004","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}